Find-A-Study

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimer’s Disease (ADEPT-4)

Purpose

Category

Child Health
Nervous System

IRB Number: STUDY00000895
NCT Number: -
Sponsor: -

Study Contact

Principal Investigator
Antonio Lucio Teixeira Junior

Rose Barajas
210-450-8219
barajasr@uthscsa.edu

Floyd Jones
210-450-3158
jonesfa@uthscsa.edu

Amy Saklad
210-567-8229
saklada@uthscsa.edu

Eligibility

Eligible Ages
Eligible Genders
Accepts Healthy Volunteers: No

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups